Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00198-024-07251-w
PubMed Identifier: 39365433
Publication URI: http://europepmc.org/abstract/MED/39365433
Type: Journal Article/Review
Volume: 35
Parent Publication: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Issue: 12
ISSN: 0937-941X